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Anti-lipid IgG antibodies are produced in some mycobacterial infections and in certain 
autoimmune diseases [such as anti-phospholipid syndrome, systemic lupus erythema-
tosus (SLE)]. However, few studies have addressed the B cell responses underlying the 
production of these immunoglobulins. Anti-lipid IgG antibodies are consistently found 
in a murine model resembling human lupus induced by chlorpromazine-stabilized non- 
bilayer phospholipid arrangements (NPA). NPA are transitory lipid associations found in 
the membranes of most cells; when NPA are stabilized they can become immunogenic 
and induce specific IgG antibodies, which appear to be involved in the development of 
the mouse model of lupus. Of note, anti-NPA antibodies are also detected in patients 
with SLE and leprosy. We used this model of lupus to investigate in  vivo the cellular 
mechanisms that lead to the production of anti-lipid, class-switched IgG antibodies. 
In this murine lupus model, we found plasma cells (Gr1−, CD19−, CD138+) producing 
NPA-specific IgGs in the draining lymph nodes, the spleen, and the bone marrow. We 
also found a significant number of germinal center B cells (IgD−, CD19+, PNA+) specific 
for NPA in the draining lymph nodes and the spleen, and we identified in situ the pres-
ence of NPA in these germinal centers. By contrast, very few NPA-specific, extrafollicular 
reaction B cells (B220+, Blimp1+) were found. Moreover, when assessing the anti-NPA 
IgG antibodies produced during the experimental protocol, we found that the affinity of 
these antibodies progressively increased over time. Altogether, our data indicate that, 
in this murine model resembling human lupus, B cells produce anti-NPA IgG antibodies 
mainly via germinal centers.
Keywords: non-bilayer phospholipid arrangements, systemic lupus erythematosus, anti-lipid igg antibodies, 
antigen-specific cells, autoimmune disease
inTrODUcTiOn
Anti-lipid IgG antibodies are produced during malaria, mycobacterial infections, autism spectrum 
disorders, and some autoimmune diseases, such as the anti-phospholipid syndrome and systemic 
lupus erythematosus (SLE) (1–4). Likewise, anti-lipid IgGs are consistently found in a mouse model 
of lupus that has several of the clinical and pathological features of SLE patients, including serum 
FigUre 1 | nPa as detected by freeze-fracture electron microscopy, together with a schematic representation. Freeze-fracture electron microscopy of 
liposomes made of l-α-phosphatidylcholine (PC)/L-α-phosphatidic acid (PA) (2:1 molar ratio) alone (a) or incubated with chlorpromazine (CPZ) 3 mM (B). The black 
arrows indicate the shadow direction and the white arrows show NPA, either isolated or forming small strings. Schematic representation illustrates the molecular 
organization of the phospholipids in a smooth liposome without NPA (c) or bearing NPA (D). The amplifications to the right depict the phospholipids in the bilayer 
arrangements (e) and in the NPA (F). The bilayers in the NPA are mainly formed by PC, whose polar regions (blue color) are exposed on the zones of the lipid bilayer 
where the inverted micelle is inserted. The novel exposure of these polar regions of PC induces the production of antibodies against them. The inverted micelle is 
mainly formed by PA (polar regions in green color) together with CPZ (9). The molecular structure of CPZ is shown in (g).
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anti-nuclear, anti-histone, anti-coagulant and anti-cardiolipin 
antibodies, weight loss, glomerulonephritis, anorexia, and 
facial lesions resembling the malar rash of lupus patients (5). 
This model can be triggered either by the administration of 
chlorpromazine (CPZ), procainamide, or hydralazine, which 
induce stable non-bilayer phospholipid arrangements (NPA) 
on cell membranes, or by administering liposomes bearing 
NPA (L-NPA) elicited by these same agents or by cations, such 
as manganese, or even by injecting a NPA-specific monoclonal 
antibody (H308, which stabilizes NPA on murine cells). NPA 
are three-dimensional structures that can emerge when anionic 
phospholipids with a conical shape, such as phosphatidic acid 
(PA), phosphatidylserine, or cardiolipin, produced an interme-
diate form of the tubular hexagonal phase II or inverted micelle 
that is inserted in a bilayer of lipids (Figure 1) (6–8). NPA are 
transient lipid associations found on the membrane of most cells; 
when they are stabilized, they can become immunogenic and 
induce the production of specific antibodies that participate in 
the pathogenesis of this mouse model of lupus (5, 9); moreover, 
anti-NPA antibodies are found in patients with SLE and leprosy 
(5, 10). On the other hand, liposomes made of a lipid extract 
from Mycobacterium smegmatis elicit high titers of anti-lipid 
IgG antibodies, which are cross-reactive with lipid antigens 
from Mycobacterium tuberculosis (1). However, few studies have 
addressed the cellular reactions that lead to the production of 
these anti-lipid IgG antibodies.
In adaptive antibody responses to most protein antigens, 
activation and proliferation of B cells occur either in secondary 
follicles where B cells form germinal centers, or in extrafol-
licular foci (11–13). Germinal center B cells (IgD−, CD19+, 
PNA+) switch the antibody isotype and mutate the genes that 
encode their antigen receptors. These processes can change the 
antibody affinity and even the antibody specificity. The mutated 
cells that produce high-affinity antibodies are selected to become 
either plasma cells (Gr1−, CD19−, CD138+) or memory B cells, 
whereas cells that have lost affinity or acquired autoreactivity 
are typically eliminated (14, 15). Normally, CD4+ T (follicular) 
helper cells are critical for the germinal center formation and the 
subsequent B cell selection. Both processes involve engagement 
of at least CD40 on B cells by CD40-ligand on T cells, although 
there are reports describing the generation of high-affinity B 
cells in large germinal centers in the absence of T cells, or in 
absence of signaling through CD40 or CD28. However, in these 
latter cases, extensive cross-linking of the B cell receptors, and a 
high frequency of antigen-specific B cells of at least 1 in 1,000, 
is required (16). Extrafollicular reactions are responsible for the 
fast production of antibodies upon antigen encounter, and the 
extrafollicular B cells (B220+, Blimp1+) are typically found in 
the medullary cords of lymph nodes and in foci in the spleen 
red pulp. In some circumstances, the extrafollicular responses 
can be associated with immunoglobulin class switching but, at 
the most, with only low levels of hypermutation (11, 17). In our 
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study, we used an established murine model resembling human 
lupus induced by the stabilization of NPA to investigate if the 
cellular mechanisms that lead to the production of anti-NPA IgG 
antibodies are through germinal centers or through extrafol-
licular reactions.
MaTerials anD MeThODs
Preparation and characterization of 
liposomes and liposomes Bearing nPa
Egg yolk l-α-PA, egg yolk l-α-phosphatidylcholine (PC) and 
CPZ were purchased from Sigma Aldrich (St. Louis, MO, USA). 
Liposomes were formed with the cylindrical phospholipid PC 
and the anionic and conical phospholipid PA in a molar ratio 
of 2:1. Nine micromoles of the phospholipid mixture were dis-
solved in 1 mL of diethyl ether, 330 μL of TS (10 mM Tris-HCl, 
1 mM NaCl, pH 7) were added, and the mixture was sonicated 
three times (5-s sonication followed by 30 s resting period) in a 
Lab Supply G112SPI sonicator (Laboratory Supplies, Hicksville, 
NY, USA). The diethyl ether was then removed under a stream 
of oxygen-free dry nitrogen at reduced pressure, using a rotary 
evaporator at 37°C. TS was added to a final volume of 1 mL and 
the liposomes were filtered through MF-Millipore membranes 
(Billerica, MA, USA) with 0.45 μm pores. To induce the forma-
tion of NPA, liposomes in TS were incubated 30  min at 37°C 
in the presence of CPZ (3  mM) (18). To stain the liposomes, 
100  μL of the red-fluorescent PKH26 dye (Sigma Aldrich) 
diluted 1:500 in diluent C (Sigma Aldrich) were added to 100 μL 
of smooth liposomes (SL) or L-NPA and incubated for 5 min at 
room temperature. To stop the staining, 200 μL of phosphate 
buffered saline (PBS) with 1.0% bovine serum albumin (BSA) 
(US Biologicals, Swampscott, MA, USA) were added, and then 
centrifuged at 268,000 ×  g for 15  min in the ultracentrifuge 
Optima TM MAX-XP (Beckman Coulter, Brea, CA, USA). The 
supernatant was discarded and the liposomes resuspended in 
PBS. All the final preparations of liposomes were negative for 
LPS contamination, as assessed by the gel clot LAL method 
(Charles River Endosafe, Charleston, SC, USA). The final prepa-
rations were evaluated by freeze-fracture electron microscopy, 
as reported before (9).
Mouse Model of lupus
To induce the lupus-like disease in mice, we used the protocol 
as described before (5, 9). Briefly, we used three groups (A, B, 
and C) of 6-week-old female pathogen-free BALB/c mice. 
Each group was divided into three subgroups of six mice each. 
Subgroup one received saline solution (SS), subgroup two SL 
and subgroup three liposomes bearing CPZ-induced NPA, on 
days 1 and 16 (50 μL, intrasplenic). Before the first injection, 
mice received intraperitoneally 100  μL of complete Freund’s 
adjuvant (CFA, Sigma Aldrich) diluted 1:2 with TS, and before 
the second injection, the mice received 100 μL of incomplete 
Freund’s adjuvant (Sigma Aldrich) diluted 1:2 with TS. 
Additionally, on days 2, 17, and 32, 50 μL of SS, SL, or liposomes 
bearing CPZ-induced NPA, were injected intradermally in the 
inguinal region of these mice, instead of the intraperitoneal 
region as was previously described (5). Blood was taken before 
and 10, 20, and 35  days after the first intra-splenic injection. 
Sera were heated at 56°C for 30 min to inactivate complement, 
and then frozen in aliquots at −70°C. Mice of groups A, B, and 
C were sacrificed on days 10, 20, and 35, respectively, after the 
first intra-splenic injection (Protocol illustrated in Figure S1 in 
Supplementary Material).
The spleens and inguinal lymph nodes (ILN) of each mouse 
of the A, B, or C groups were extracted, sectioned and the cell 
suspensions obtained were placed in fluorescence-activated cell 
sorting (FACS) buffer solution containing PBS with 0.1% BSA 
and 0.01% sodium azide (Sigma Aldrich) for flow cytometry 
analysis. Bone marrows were extracted and placed also in FACS 
buffer solution for flow cytometry studies. All our protocols for 
animal care and use were reviewed and approved by the Bioethics 
Committee of our Institution following international rules (19).
confirmation of the Development of the 
lupus-like Disease in Mice in response 
to intradermal injection of liposomes 
Bearing nPa
A group of 10 mice was injected intradermally in the inguinal 
region once a week with liposomes bearing CPZ-induced NPA, 
and sacrificed 4  months after the first intra-splenic injection 
to confirm that these mice, which were injected intradermally 
instead of intraperitoneally, also developed the autoimmune 
disease resembling human lupus. Blood samples were taken every 
month, anti-NPA antibodies, as well as anti-histone and anti-
cardiolipin antibodies, were measured in their sera, as reported 
before (5). A goat peroxidase-tagged anti-mouse antibody to IgG, 
IgM, and IgA isotypes was used to assess total antibodies to NPA; 
whereas goat peroxidase-tagged anti-mouse to total IgGs (Sigma 
Aldrich) diluted 1:2,000 was used as a secondary antibody in the 
ELISA to determine NPA-specific IgG antibodies only. Where 
indicated, L-NPA stained with the PKH26 red-fluorescent dye 
were used as antigens in the ELISA, in order to verify that NPA-
fluorescent labeling did not modify the Ab recognition of NPAs.
identification of nPa-specific B cells and 
Plasma cells by Flow cytometry
Inguinal lymph nodes, spleens, and bone marrow were macer-
ated in glass mortars and then filtered with a 75 μm cell strainer 
(Becton Dickinson, San Jose, CA, USA). The organs from two 
mice from the same subgroup were pooled together for analysis. 
Red blood cells from spleens were lysed and cell suspensions were 
resuspended in FACS buffer solution. Before staining, cells were 
incubated with Universal Blocking Reagent (Block Biogenex, San 
Ramón, CA, USA) diluted 1:10 with PBS for 10 min at 4°C and 
then washed. Plasma cells, germinal center, and extrafollicular B 
cells were labeled with the corresponding set of antibodies indi-
cated below, and with L-NPA, which were previously stained with 
the lipophilic red-fluorescent dye PKH26. This latter procedure 
allowed us, therefore, to analyze the populations specific for the 
inducing antigen (NPA).
To evaluate NPA-specific germinal center B cells, cell suspen-
sions were labeled with anti-IgD-PerCP/Cy5.5, anti-CD19-APC 
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and PNA-FITC (Vector Laboratories, Burlingame, CA, USA) 
and 10 μL of the PKH26-stained liposomes for 30 min at 4°C 
and then washed and fixed with 1% paraformaldehyde (Sigma 
Aldrich).
Extrafollicular B cells were labeled with anti-B220-FITC, 
anti-CD5-AF647, and 10 μL of the PKH26-stained liposomes for 
30 min at 4°C and then washed. Subsequently, 50 μL of Cytofix/
Citoperm (Becton Dickinson) was added; and after 10 min at 4°C, 
the cells were washed with PermWash buffer (Becton Dickinson) 
1×; an anti-Blimp1-biotinylated antibody (Abcam, Burlingame, 
CA, USA), followed by streptavidin coupled to Pacific Blue 
(Invitrogen, Carlsbad, CA, USA) diluted in 50 μL of PermWash 
buffer, was added, and the cells were incubated for 30 min at 4°C. 
The cells were washed a final time with PermWash buffer and 
fixed with 1% paraformaldehyde.
To evaluate NPA-specific plasma cells, cell suspensions were 
labeled first with anti-Gr1-PerCP, anti-CD19-APC, and with 
anti-CD138-Brilliant Violet 421 for 30  min at 4°C and then 
washed. Subsequently the procedure for intracellular labeling 
was as described: 50 μL of Cytofix/Citoperm was added; and 
after 10  min at 4°C, the cells were washed with PermWash 
buffer. Anti-IgG-FITC (Jackson Immunoresearch) diluted in 
50  μL of PermWash buffer and 10  μL of the PKH26-stained 
liposomes were added, the cells were incubated for 30  min 
at 4°C, washed with PermWash buffer and fixed with 1% 
paraformaldehyde.
The samples were acquired in a BD LSR Fortessa cytometer 
(Becton Dickinson) and analyzed with FlowJo 10.0.6 (Tree Star, 
Inc., Ashland, OR, USA). Appropriate isotype controls were 
included in all sets of experiments. All antibodies were from 
BioLegend (San Diego, CA, USA) unless otherwise indicated.
In Situ identification of nPas in germinal 
centers by immunofluorescence
To identify NPAs in germinal centers, mice were sacrificed at day 
35 after NPA inoculations and the ILNs were removed, embed-
ded in Tissue-Tek (Sakura Finetek, Torrance, CA, USA), frozen, 
and stored at −70°C. Tissues were cut in 6-μm sections using a 
cryostat (Leica 1900 CM, Wetzlar, DE), sections were mounted 
on poly-l-Lysine-charged slides, fixed in 2% formaldehyde 
(Polysciences, Warrington, PA, USA) for 1 h at room temperature 
and washed in PBS containing 0.1% BSA. Tissue sections were 
treated with Universal Blocking Reagent (1:10) for 10 min at room 
temperature, and with mice sera diluted 1:10 in PBS for 10 min at 
room temperature. ILN sections were incubated overnight at 4°C 
with the following combination of antibodies: biotinylated H308 
(NPA-specific) mouse monoclonal antibody and PNA-FITC, or 
with H308 and rat anti-IgD (Becton Dickinson) or with H308 and 
rat anti-B220 (Becton Dickinson). After further washes, slides 
were incubated 1  h at room temperature with anti-rat-AF488 
(Thermo Fisher Scientific, Waltham, MA, USA) and washed 
three times. Subsequently, the slides were incubated for 15 min 
at room temperature with streptavidin-AF610 (Thermo Fisher 
Scientific) and washed. Finally, blue nuclear counter-staining was 
done using DAPI (Invitrogen) for 5 min at room temperature and 
the slides were washed. Slides were then mounted with DABCO 
(Sigma Aldrich) and examined with Image-Pro PLUS software in 
an Olympus BX51 microscope (Olympus Corporation, Hachioji, 
TY, JPN). Appropriate isotype controls were included in each 
experiment.
anti-nPa igg antibodies and affinity 
Maturation during the experimental 
Procedure
To determine whether the IgG antibodies to NPA underwent 
affinity maturation during the time course of the experimental 
protocol, we performed antigen-specific ELISAs for the anti-
NPA IgG antibodies, both in the absence and in the presence 
of urea (Sigma Aldrich) 7M (20–22). ELISAs were performed 
as indicated above (5), but after adding the sera containing the 
anti-NPA IgG antibodies, urea 7M was added to each well for 
10 min (secondary reagents were added after the corresponding 
washes). Under the astringent effects of urea, the antibodies 
with low affinities for antigen will detach more easily than the 
antibodies bound with higher affinities, and the result of this 
can be quantitated. Therefore, in this assay, the percentage of 
urea-resistant IgG anti-NPA antibodies can be calculated regard-
ing the total IgG anti-NPA antibodies. The kinetic follow-up of 
this behavior during the immunization procedures will indicate 
whether affinity maturation of these antibodies has occurred. 
While low percentage indicates that most NPA-specific antibod-
ies detached from antigen (low affinity), high percentage reveals 
that most antibodies remained attached to antigen despite the 
high-stringency urea wash (high affinity).
resUlTs
characterization of liposomes Bearing 
cPZ-induced nPa
Freeze-fracture electron microscopy of PC/PA (2:1) liposomes 
revealed vesicles with smooth surfaces (Figure 1A), as previously 
described (9, 18). The addition of 3 mM CPZ induced the forma-
tion of NPA (Figure 1B), which have an average thickness of 5 nm; 
these NPA are isolated or form small strings that do not modify 
the liposome size. PC/PA (2:1) liposomes bearing CPZ-induced 
NPA and stained with PKH26 dye showed an image similar to 
the liposomes bearing CPZ-induced NPA, which have not been 
PKH26-stained (data not shown). A schematic representation of 
SL, or L-NPA, is shown (Figures 1C–G).
Mice inoculated with liposomes Bearing 
nPa Produce igg anti-nPa antibodies
Anti-NPA antibodies were readily detected in the sera of mice 
that received L-NPA intradermally; while these antibodies were 
not detected in mice that received only SL or SS. A proportion 
of the anti-NPA antibodies (13, 43, and 71% on days 10, 20, and 
35 after first immunization, respectively) were of the IgG class 
(Figure  2A). In the mice that were injected intradermally in 
the inguinal region with L-NPA, anti-NPA antibodies were also 
detected since the 10th day after the first inoculation, and these 
antibodies increased progressively until the fourth month. Anti-
histone and anti-cardiolipin antibodies were detected a month 
later than the anti-NPA antibodies, and they also increased 
FigUre 2 | Mice injected with liposomes bearing nPa produced igg antibodies that specifically bind to nPa. Sera of mice injected either with saline 
solution, with smooth liposomes, or with liposomes bearing NPA were assayed by ELISA at the indicated days using as antigen the liposomes bearing NPA. Goat 
anti-mouse antibody to the IgG, IgM and IgA isotypes was used to assess total antibodies to NPA; whereas goat anti-mouse to IgG was used to assess only the 
IgG specific to NPA (a). Anti-NPA, anti-histones, and anti-cardiolipin antibodies were also measured by ELISA in the sera of mice injected intradermally with 
liposomes bearing NPA once a week for 4 months (B); 60% of these mice developed facial lesions, as indicated by the arrows (c).
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progressively until the fourth month (Figure 2B), which is con-
sistent with previous reports (5, 9). These mice also developed 
facial lesions on the second month after the first injection of 
L-NPA (Figure 2C).
Plasma cells That Produce iggs specific 
to nPa are Found in Mice with the lupus-
like Disease
To investigate the in  vivo cellular mechanisms that lead to the 
production of IgG anti-NPA antibodies in this mouse model of 
lupus, we used flow cytometry. Cell suspensions were labeled 
with antibodies and with L-NPA stained with the red-fluorescent 
lipophilic dye PKH26, in order to identify cell populations spe-
cific for the inducing NPA antigen. PKH26-stained liposomes 
were tested as antigens in an ELISA, and no significant differences 
in the anti-NPA antibody titers were found, compared to non-
stained L-NPA (data not shown). Specific plasma cells for NPA 
(Gr1−, CD19−, CD138+, NPA+) were identified by flow cytometry 
(Figures 3A–D) in the draining lymph nodes, the spleen and the 
bone marrow of mice that received L-NPA; these NPA-specific 
plasma cells were not observed in mice that received either SL or 
SS (Figures 3E,F). The percentage of IgG+ NPA-specific plasma 
cells increased progressively, from 0.78, 1.5, and 1.63% on day 
10 to 2.67, 7.04, and 7.27% on day 35 for the draining lymph 
nodes, the spleen and bone marrow, respectively (Figures 3G–I). 
Concomitantly, the percentage of IgG− NPA-specific plasma cells 
decreased progressively from 0.75 and 7.2% on day 20 to 0.41 and 
5.15% on day 35 for the draining lymph nodes and the spleen, 
respectively (Figures 3J,K); and from 6.48% on day 10 to 2.19% 
on day 35 for bone marrow (Figure 3L).
nPa-specific germinal center B cells 
are Found in Mice with the lupus-like 
Disease
Germinal center B cells specific for NPA (IgD−, CD19+, PNA+, 
NPA+) were identified by flow cytometry (Figures  4A–D) in 
the draining lymph nodes and the spleen of mice that received 
L-NPA; these germinal center B cells were not found in mice that 
received only SL or SS (Figures 4E,F). The percentage of NPA-
specific germinal center B cells increased progressively from 4.37 
and 6.15% on day 10 to 16.37 and 19.87% on day 35 for the drain-
ing lymph nodes and the spleen, respectively (Figures 4G,H).
Few nPa-specific extrafollicular B cells 
are Found in Mice with the lupus-like 
Disease
Few NPA-specific B1 (B220+, CD5+, Blimp1+, NPA+) and 
B2 (B220+, CD5-, Blimp1+, NPA+) cells that respond in an 
extrafollicular manner were identified by flow cytometry 
(Figures  5A–F) in the spleen of mice that received L-NPA; 
FigUre 3 | nPa-specific plasma cells from mice inoculated with liposomes bearing nPa. To identify NPA-specific plasma cells, cell suspensions from the 
draining lymph nodes, spleen, and bone marrow were co-labeled with antibodies to surface Gr1, CD19, and CD138 and intracellularly for IgG and with PKH26-
stained liposomes bearing NPA (NPA-PE), and were then analyzed by flow cytometry. Gating strategy to identify plasma cells specific to NPA (Gr1−, CD19−, CD138+, 
NPA+) (a). Region analysis shows the percentage of NPA-specific IgG+ and IgG− plasma cells on days 10 (B) 20 (c), and 35 (D) in the bone marrow of mice that 
had been inoculated with NPA-liposomes. Percentage of NPA-specific IgG+ and IgG− plasma cells on day 35 in the spleens of mice inoculated with saline solution 
(e) or with smooth liposomes (F). Percentage of IgG+ or IgG− plasma cells specific to NPA in the draining lymph nodes (g,J), spleen (h,K), and bone marrow (i,l). 
Kruskal–Wallis test with Dunn’s post-test were used for statistical analysis; significance was set at P < 0.05. Asterisks represent statistically significant differences 
between the indicated groups (*P < 0.05, ***P < 0.001). Each symbol represents pooled cells from two mice. SS, saline solution; SL, smooth liposomes; LB NPA, 
liposomes bearing NPA.
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FigUre 4 | germinal center B cells specific to nPa from mice inoculated with liposomes bearing nPa. In order to identify NPA-specific germinal center B 
cells, cell suspensions from the draining lymph nodes and spleens were co-labeled with red-fluorescent PKH26-stained liposomes bearing NPA (NPA-PE), with 
antibodies to surface IgD and CD19 and with fluorescent PNA and analyzed by flow cytometry. Gating strategy to identify NPA-specific germinal center B cells (IgD−, 
CD19+, PNA+, NPA+) (a). Region analysis shows the percentage of NPA-specific germinal center B cells on days 10 (B), 20 (c), and 35 (D) in the spleens of mice 
that had been inoculated with NPA-liposomes. Percentage of NPA-specific germinal center B cells on day 35 in the spleens of mice inoculated with saline solution 
(e) or with smooth liposomes (F). Percentages of germinal center B cells specific to NPA in the draining lymph nodes (g) and spleen (h). Kruskal–Wallis test with 
Dunn’s post-test were used for statistical analysis; significance was set at P < 0.05. Asterisks represent statistically significant differences between the indicated 
groups (*P < 0.05, ***P < 0.001). Each symbol represents pooled cells from two mice. SS, saline solution; SL, smooth liposomes; LB NPA, liposomes bearing NPA.
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however only extrafollicular B2 cells specific to NPA were 
identified in the draining lymph nodes. These extrafollicular 
reaction B cells were not observed in mice that received only 
SL or SS (Figures  5G,H). The percentage of extrafollicular 
reaction B1 cells specific for NPA decreased progressively from 
0.72% on day 10 to 0.0% on day 35 in the spleen (Figure 5J); 
while these cells were not detected in the draining lymph nodes 
of any of the groups examined (Figure 5I). The percentage of 
extrafollicular reaction B2 cells specific for NPA decreased pro-
gressively from 0.35 and 1.69% on day 10 to 0.0 and 0.19% on 
day 35 for the draining lymph nodes and the spleen, respectively 
(Figures 5K,L).
nPas are Found in the germinal centers 
of Mice with the lupus-like Disease 
induced by nPa-immunizations
Using the NPA-specific monoclonal antibody H308, NPAs were 
identified by immunofluorescence in the germinal centers of 
the draining lymph nodes 35  days after mice received L-NPA. 
FigUre 5 | Few extrafollicular reaction B cells specific to nPa were found in mice inoculated with liposomes bearing nPa. To identify NPA-specific 
extrafollicular reaction B cells, cell suspensions from the draining lymph nodes and spleen were concomitantly labeled with red-fluorescent PKH26-stained liposomes 
bearing NPA (NPA-PE), with antibodies to surface B220 and CD5 and to intracellular Blimp1, and analyzed by flow cytometry on the indicated days. Gating strategy to 
identify extrafollicular reaction B1 (B220+, CD5+, Blimp1+, NPA+) (a,B,c) and B2 (B220+, CD5−, Blimp1+, NPA+) (a,B,D) cells specific to NPA. Region analysis shows 
the percentage of NPA-specific extrafollicular reaction B2 cells on days 10 (D), 20 (e), and 35 (F) in the spleens of mice that had been inoculated with NPA-liposomes. 
Percentage of NPA-specific extrafollicular reaction B2 cells on day 35 in the spleens of mice inoculated with saline solution (g) or with smooth liposomes (h). 
Percentages of extrafollicular reaction B1 and B2 cells specific to NPA in the draining lymph node (i,K) and spleen (J,l), respectively. Kruskal–Wallis test with Dunn’s 
post-test were used for statistical analysis; significance was set at P < 0.05. Asterisks represent statistically significant differences between the indicated groups 
(*P < 0.05, **P < 0.01). Each symbol represents pooled cells from two mice. SS, saline solution; SL, smooth liposomes; LB NPA, liposomes bearing NPA.
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FigUre 6 | nPas can be found in germinal centers from draining lymph nodes of mice with lupus-like disease induced by nPa-immunizations. The 
NPAs (identified with the monoclonal antibody H308, red fluorescence) were assessed in a series of double stainings with H308 and anti-B220 (green fluorescence) 
(a,B), or with H308 and anti-IgD (green fluorescence) (c,D), or with H308 and PNA (green fluorescence) (e,F), in serial tissue sections from the draining inguinal 
lymph nodes of mice that developed the lupus-like disease. B cell follicles can be identified in situ with B220 [(a,B), green fluorescence]. A negative IgD area [(c,D), 
green fluorescence] inside B cell follicles indicates the germinal center; and this same IgD-negative zone corresponds to the PNA-positive labeling in the contiguous 
section [(e,F), green fluorescence]. Nuclei counter-staining was done with DAPI (blue fluorescence). Germinal centers were distributed along the tissues and NPA 
staining revealed the positive cells in germinal centers (arrows). Representative pictures of three independent experiments are shown. For each marker, the images 
to the right (40×, scale bar = 50 μm) correspond to the red squares indicated on the images to the left (10×, scale bar = 200 μm). Co-localization of a given marker 
(green fluorescence) with NPA (red fluorescence) appears as orange-yellow. Images with individual colors are shown in Figure S2 in Supplementary Material.
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B220 delineates the B cell follicles (Figures 6A,B) and an IgD-
negative area inside B cell follicles indicates the germinal centers 
(Figures 6C,D). These IgD-negative areas are positive for PNA 
(Figures 6E,F).
The affinity of the anti-nPa igg antibodies 
Progressively increases over Time
To determine if affinity maturation, a hallmark of the antibodies 
produced via germinal center reactions, occurs during the course 
of the NPA-immunizations, we performed antigen-specific 
ELISAs for the anti-NPA IgG antibodies, both in the absence 
and in the presence of urea 7M. This is a well-established assay 
(20–22) used to test antibody affinities. Lower antibody affini-
ties correlate with increased antibody decoupling from antigen 
under the astringent effects of urea. Conversely, higher antibody 
affinities lead to an increased proportion of antibodies that resist 
the effects of urea and remain bound to antigen. Using this assay, 
we obtained at each time point the percentage of urea-resistant 
FigUre 7 | The affinity of the anti-nPa igg antibodies increases with 
time after immunization. Sera of mice injected at different time points with 
liposomes bearing NPA were assayed by ELISA on the indicated days, using 
liposomes bearing NPA as antigen, and goat anti-mouse IgG as secondary 
antibody. After incubation of the anti-NPA antibodies, urea 7M was added to 
each well for 10 min (secondary reagents were added after this). At each time 
point, the percentage of urea-resistant anti-NPA IgG antibodies (high affinity, 
shown in gray bars) and the total anti-NPA IgG antibodies (indicated with 
dotted bars) are represented. The progressive increase in the affinity of the 
IgG anti-NPA antibodies is indicated with the continuous red line; at late time 
points (day 35 onwards) most antibodies display high affinities. Percentages 
of urea-resistant antibodies at the indicated times were analyzed with 
Kruskal–Wallis test with Dunn’s post-test; significance was set at P < 0.05. 
Asterisks represent statistically significant differences between the indicated 
groups (*P < 0.05, **P < 0.01, ***P < 0.001).
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(high affinity) anti-NPA IgG antibodies, in relation to the total 
anti-NPA IgG antibodies. As illustrated in Figure 7, the propor-
tion of urea-resistant antibodies was much lower at early time 
points (10 and 20 days post-NPA-injection) than at later time 
points (35, 60, 90, and 120 days post-NPA injection), which indi-
cates that affinity has increased with time. In fact, at days 35, 60, 
90, and 120 post-immunization, most anti-NPA IgG antibodies 
showed high affinities, revealing the maturation of affinity.
DiscUssiOn
Compared to proteins, lipids are deemed rather poorly immu-
nogenic molecules (3). However, anti-lipid antibodies have been 
found in patients with infectious diseases, such as leprosy and 
tuberculosis (1, 10), and in patients with autoimmune diseases 
such as SLE (4); these antibodies are not only low-affinity IgM, 
but also high-affinity class-switched IgG antibodies. The cellular 
mechanisms that lead to the production of these IgM and IgG 
anti-lipid antibodies have not been elucidated and are poorly 
studied. To investigate these mechanisms, we assessed a mouse 
model of an autoimmune disease resembling human lupus, which 
develops in response to the administration of NPA (9). NPA are 
transient phospholipid molecular arrangements, different from 
the bilayer formed by lipids from cell membranes (8). These 
phospholipid associations are observed by electron microscopy 
as protuberances on the lipid matrix of liposomes (artificial 
membrane models). When lipids are associated in stable NPA, 
they become more immunogenic and induce the production of 
specific antibodies (5, 9). Here, we report for the first time that, in 
mice that developed an autoimmune disease resembling human 
lupus in response to the administration of NPA, B cells reacted 
mainly through the germinal centers to produce anti-NPA IgG 
antibodies.
In NPA, the polar heads of the phospholipids that form the 
outer region of this lipid structure are separated from each other, 
so they are exposed as new antigens; however, since NPA are 
transient structures, usually no immune response is elicited (5). 
Of note, when NPA are stabilized by drugs that induce lupus-like 
diseases in humans (23), such as CPZ, promazine, procainamide, 
and hydralazine, an immune response is generated with the pro-
duction of anti-NPA antibodies. Interestingly, in mice, these same 
drugs trigger the development of an autoimmune disease similar 
to human lupus. We have already demonstrated, with hapten 
inhibition studies, that the epitope recognized by these antibodies 
is glycerolphosphorylcholine, the polar region of PC, which is the 
most abundant phospholipid in animal cell membranes (9).
In previous studies, we found that a high percentage (60%) 
of the anti-NPA antibodies that are found in the mice with the 
lupus-like disease are of the IgG class. To study the mechanisms 
that lead to the production of these anti-NPA switched IgG 
antibodies, we inoculated NPA to mice by intra-splenic injection 
(as we had done it before) (5, 9), but changed the administration 
of subsequent NPA boosting doses from intraperitoneal to intra-
dermal injection in the inguinal region, so that we could monitor 
the (systemic) immune response in the spleen and in the draining 
(regional) lymph node. The mice that received NPA by the intra-
dermal route also generated anti-NPA antibodies, and 45% of 
these antibodies were IgG. These mice produced anti-cardiolipin 
and anti-histone antibodies 1 month after the appearance of the 
anti-NPA antibodies, and 60% of the mice had malar rash. These 
results indicate that these mice had an autoimmune disease with 
very much the same characteristics to the disease that develops 
in response to the administration of NPA by the intraperitoneal 
route, as we previously reported (5, 9).
During the production of class-switched IgG antibodies 
against most protein antigens, B cells respond in vivo mainly via 
the germinal center or (to a lesser degree) the extrafollicular reac-
tion, and subsequently differentiate into plasmablasts and plasma 
cells that produce IgG antibodies (11, 14, 24). To identify the 
specific cells producing the anti-NPA antibodies, liposomes with 
or without NPA were stained with the lipophilic (red fluorescent) 
dye PKH26. This staining did not affect the structure of the NPA 
in the liposomes, because L-NPA and stained with PKH26 were 
equally recognized by anti-NPA mouse sera or even by a mono-
clonal anti-NPA antibody, while control liposomes without NPA 
but equally stained with PKH26 were not recognized by these 
anti-NPA antibodies. Therefore, L-NPA and stained with PKH26 
were used to identify anti-NPA antibody-producing cells by 
flow cytometry. With this strategy, we found plasma cells (Gr1−, 
CD19−, CD138+, NPA+) that produce anti-NPA antibodies in the 
secondary lymphoid organs (draining lymph node and spleen) of 
mice with the lupus-like disease. We also found plasma cells in the 
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bone marrow, which is the organ to which these cells can migrate 
after their differentiation in the secondary lymphoid organs (25). 
To avoid false-positive results, granulocytes (Gr1+), which can 
uptake most types of small particles and molecules, including 
antibodies, were excluded from the flow cytometry analysis.
The percentage of plasma cells that produce anti-NPA IgG 
antibodies increased gradually in the three organs analyzed 
(lymph nodes, spleen, and bone marrow), while the percentage of 
IgG-negative NPA-specific plasma cells decreased in these same 
organs at 10, 20, and 35 days after the first administration of NPA. 
This plasma-cell response is similar to that described for protein 
antigens (26). A larger number of plasma cells specific to NPA was 
found in the spleen, compared to the draining lymph node, and 
this may be attributed to the populations of B cells (B1 cells and 
marginal zone B cells) that are present in the spleen, but not in the 
lymph nodes, and which could generate such plasma cells (25).
After identifying the specific plasma cells producing anti-
NPA IgG antibodies, we investigated the route by which B cells 
responded, and found that the reaction of anti-NPA B cells was 
mainly via the germinal centers. Germinal centers provide the 
microenvironmental requirements for the interactions between 
follicular T and B cells that lead to the generation of high-affinity 
IgG antibodies against protein antigens (12). IgG antibodies 
against several lipids (lathosterol, 7-α-hydroxycholesterol, cardi-
olipin, and oxidized PC) have been found in SLE patients (27), 
and IgG antibodies against long-chain saturated fatty acids have 
been found in the sera of patients with type 2 diabetes (28). IgM 
and IgG anti-cholesterol antibodies have been detected even in 
healthy individuals, as well as in patients with atherosclerosis 
and viral infections (29–31). However, the cellular mechanisms 
that lead to the production of these anti-lipid antibodies are still 
poorly understood. The main cells providing help to B cells for 
the production of anti-lipid antibodies seem to be NKT cells 
rather than CD4 T cells. For instance, NKT cells, not conven-
tional CD4 T cells, provide cognate help to B cells specific for 
4-hydroxy-3-nitrophenyl-α-galactosyl-ceramide (NP-αGalCer), 
which produce anti-NP IgG antibodies (32). It has been shown 
that invariant-chain NKT cells (iNKT cells) can cooperate with 
B cells and induce the rapid formation of germinal centers to 
glycolipid antigens (33). iNKT cells can recognize synthetic, self- 
and microbial glycolipids, as well as self-phospholipid antigens 
presented by CD1d (34); and in patients with SLE it has been 
shown that iNKT cells promote the production of IgG antibodies 
and auto-antibodies (35). In fact, iNKT cells can adopt a phe-
notype that corresponds to that of follicular T helper cells, with 
high expression of CXCR5, PD-1, and Bcl-6, and the secretion 
of IL-4, IFN-γ, IL-21, and BAFF. These iNKT cells can be found 
in germinal centers and they provide help to B cells in a CD40–
CD40L-dependent manner, which leads to the production of IgG 
antibodies (33, 36, 37). It is, thus, conceivable that iNKT cells 
might be cooperating with B cells for the production of anti-NPA 
IgG antibodies (38), but this needs to be demonstrated.
The percentage of germinal center B cells (IgD−, CD19+, 
PNA+, NPA+) specific to NPA was higher in the lymph nodes 
and the spleen than the percentage of extrafollicular reaction B2 
cells (CD5−, B220+, Blimp1+, NPA+), especially on day 35 after 
the first immunization. We also found the antigen (NPA) inside 
the germinal centers of the draining lymph nodes of mice that 
developed the lupus-like disease. Extrafollicular reaction B1 cells 
(CD5+, B220+, Blimp1+, NPA+) were not detected in the draining 
lymph node (where they are usually absent), and very few were 
detected in the spleen, where they decreased until they became 
undetectable by day 35. In general, this pattern regarding the per-
centage of germinal center B cells and extrafollicular reaction B1 
and B2 cells that reacted against NPA is similar to that described 
for protein antigens. Affinity maturation is a crucial process dur-
ing antibody responses and occurs mainly during germinal center 
reactions; thus, the fact that we detected that the affinity of these 
anti-NPA IgG antibodies progressively augmented with time after 
immunization strongly supports the notion that these antibodies 
were produced via germinal centers.
The production of antibodies by plasma cells is a critical 
process to maintain human health as it provides immunity after 
the exposure to a pathogen and mediates the protective effects of 
most vaccines. While the B cell-differentiation process to gener-
ate plasma cells that produce antibodies to protein antigens has 
been extensively studied, reports regarding these events in the 
case of lipid antigens are scarce. However, these same anti-lipid 
antibodies-producing cells might be involved in clinically rel-
evant diseases, such as autoimmunity and infection. It is crucial, 
therefore, to understand the mechanisms of B cell differentiation 
to plasma cell, particularly as it relates to the generation of class-
switched IgG antibodies, not only in response to protein antigens 
but also to lipid antigens, which might be involved in clinically 
relevant autoimmune and infectious diseases.
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FigUre s1 | Three groups (a, B, and c) of adult mice were divided into 
three subgroups of six mice each. One subgroup received saline solution 
(SS), the other smooth liposomes (SL), and the last one liposomes bearing NPA 
(L-NPA). On day 1, group A received complete Freund’s adjuvant (CFA) 
(intraperitoneally, i.p.) and SS, SL, or L-NPA (intrasplenic, i.s.); on day 2, SS, SL, 
or L-NPA (intradermally, i.d.) and sacrificed on day 10. On day 16, group B 
received the same as group A plus incomplete Freund’s adjuvant (ICFA, i.p.) 
and SS, SL, or L-NPA (i.s.); on day 17, SS, SL, or L-NPA (i.d.) and sacrificed on 
day 20. Finally, group C received the same as groups A and B plus SS, SL, or 
L-NPA (i.d.) on day 32 and sacrificed on day 35. Samples were taken before 
immunization and on the days of sacrifice.
FigUre s2 | individual and merged images of labeled tissue sections 
from draining lymph nodes. Individual images of the draining lymph nodes 
from mice with lupus-like disease induced by NPA-immunizations were taken 
with the Olympus BX51 microscope; green fluorescence for B220 (a), IgD (e), 
and PNA (i); blue fluorescence for nuclei counter-staining (DAPI) (B,F,J) and red 
fluorescence for NPAs (c,g,K). Merged images of B220/DAPI/PNA (D), IgD/
DAPI/NPA (h), and PNA/DAPI/NPA (l). Images were merged with Image-Pro 
PLUS software.
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